URAC and ACHC accreditation in specialty pharmacy networks
Specialty pharmacy is one of the few corners of US healthcare where accreditation works as a commercial gatekeeper rather than a badge. Manufacturers launching limited-distribution drugs, PBMs building specialty networks and health plans contracting for oncology or rare-disease dispensing routinely write URAC or ACHC accreditation into their requirements. A pharmacy without one of them is usually not considered at all, and many network agreements ask for both.
The two accrediting bodies
URAC is a Washington, DC based nonprofit accreditor whose pharmacy suite includes Specialty Pharmacy Accreditation, Mail Service Pharmacy Accreditation, Infusion Pharmacy Accreditation, a Specialty Pharmacy Accreditation for Small Business, and the Rare Disease Pharmacy Center of Excellence designation. URAC also requires accredited specialty pharmacies to report performance measures; its five-year specialty pharmacy report drew on data from 451 unique specialty pharmacies covering 211 million prescriptions dispensed between 2018 and 2022.
ACHC (Accreditation Commission for Health Care) is a nonprofit accreditor founded in 1986 that holds CMS deeming authority for home health, hospice and DMEPOS. Its pharmacy program offers Specialty Pharmacy and Specialty Pharmacy without DMEPOS accreditation, plus optional distinctions that matter for therapeutic-area networks: Oncology, Rare Diseases and Orphan Drugs, Ig Therapy, Infectious Disease Specific to HIV, and Nutrition Support.
Why both directories need to be read together
URAC and ACHC each publish their own directory, organized by accreditation number and site rather than by pharmacy organization. A single specialty pharmacy can appear several times: CVS Specialty, for example, reports separate URAC Specialty Pharmacy accreditation for its mail pharmacies (since 2010) and its retail specialty pharmacies (since 2019), alongside ACHC Specialty Pharmacy Services accreditation and an ACHC Rare Diseases and Orphan Drugs distinction. Network managers who need to know which organizations hold both accreditations, and which hold the therapeutic distinctions relevant to a given product, have to reconcile the two registries by hand.
| Credential | Issued by | Typical use in network design |
|---|---|---|
| Specialty Pharmacy Accreditation | URAC | Baseline requirement for PBM and payer specialty networks |
| Rare Disease Pharmacy Center of Excellence | URAC | Screening pharmacies for ultra-orphan and rare-disease launches |
| Specialty Pharmacy accreditation | ACHC | Alternative or second accreditation for manufacturer LDD panels |
| Oncology distinction | ACHC | Oral oncolytic and oncology-focused networks |
| Rare Diseases and Orphan Drugs distinction | ACHC | Orphan drug limited-distribution networks |
| Mail Service Pharmacy Accreditation | URAC | Home-delivery dispensing requirements |
How manufacturers and PBMs use accreditation
- Limited-distribution panels: trade teams typically shortlist pharmacies that hold dual accreditation and a matching therapeutic distinction, then evaluate data-reporting capability, payer access and patient support services.
- Payer and PBM networks: credentialing teams verify current accreditation and expiry dates at each contracting cycle, because accreditation is granted for a fixed term and must be renewed through resurvey.
- Competitive mapping: the mix of independent, health-system, payer-owned and PBM-owned pharmacies holding the same credentials shapes how open or closed a specialty network is in practice.
Reading the credentials carefully
Accreditation is granted to a legal entity and often to specific sites, and pharmacies tend to display it as badges with expiry dates. When evaluating a pharmacy, check which locations the accreditation covers, whether a distinction is an add-on to a current base accreditation, and when the term expires. Health-system specialty pharmacies, independent rare-disease pharmacies and the large PBM-affiliated operators all hold the same base accreditations, so the distinctions and the scope of accredited sites are often what separates them.